Submit your email to push it up the queue
Norwood Medical Corporation, a leading name in the medical device industry, is headquartered in the United States. Founded in 1997, the company has established itself as a key player in the development and manufacturing of innovative medical solutions, particularly in the fields of surgical instruments and advanced wound care products. With a strong operational presence across North America and Europe, Norwood Medical is renowned for its commitment to quality and precision. The company’s core offerings include custom surgical instruments and proprietary wound care technologies, which are distinguished by their reliability and effectiveness. Norwood Medical has achieved significant milestones, including ISO certification and partnerships with major healthcare providers, solidifying its market position as a trusted supplier in the medical sector.
How does Norwood Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Norwood Medical Corporation's score of 43 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Norwood Medical Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Heraeus Holding GmbH, which may influence its climate commitments and emissions reporting. As of now, Norwood Medical Corporation has not established any documented reduction targets or climate pledges. However, it is important to note that emissions data and climate initiatives may be cascaded from its parent company, Heraeus Holding GmbH. This relationship could potentially align Norwood Medical with broader sustainability goals and initiatives set by Heraeus. In the absence of specific emissions figures, Norwood Medical Corporation's commitment to addressing climate change remains unclear. The company may benefit from leveraging the sustainability frameworks and targets established by Heraeus Holding GmbH, which could enhance its environmental performance in the future.
Access structured emissions data, company-specific emission factors, and source documents
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Scope 1 | 20,488,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 40,897,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Norwood Medical Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.